{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:56:19Z","timestamp":1767707779688,"version":"3.41.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-02688-3","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:11:53Z","timestamp":1751375513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diabetes mellitus in patients with HIV na\u00efve to antiretroviral therapy initiating integrase inhibitors therapy"],"prefix":"10.1038","volume":"15","author":[{"given":"Sara","family":"Dias da Costa","sequence":"first","affiliation":[]},{"given":"Ema","family":"Bichan\u00e7a","sequence":"additional","affiliation":[]},{"given":"Filipe","family":"Cruz","sequence":"additional","affiliation":[]},{"given":"Andr\u00e9 Rodrigues","family":"Guimar\u00e3es","sequence":"additional","affiliation":[]},{"given":"Carmela","family":"Pi\u00f1eiro","sequence":"additional","affiliation":[]},{"given":"Hugo","family":"Santos-Sousa","sequence":"additional","affiliation":[]},{"given":"Ros\u00e1rio","family":"Serr\u00e3o","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Freitas","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"2688_CR1","unstructured":"UNAIDS. The Path That Ends AIDS: UNAIDS Global AIDS Update 2023. (2023)."},{"key":"2688_CR2","unstructured":"European AIDS Clinical Society Guidelines 2023 Version 12.0. (2023)."},{"key":"2688_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12977-022-00608-1","volume":"19","author":"AV Zhao","year":"2022","unstructured":"Zhao, A. V. et al. A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection. Retrovirology 19, 22 (2022).","journal-title":"Retrovirology"},{"key":"2688_CR4","unstructured":"WHO. Consolidated Guidelines on HIV Prevention, Testing, Treatment, Service Delivery and Monitoring: Recommendations for a Public Health Approach. 2021 Update Ed. (2021)."},{"key":"2688_CR5","unstructured":"IDF. IDF Diabetes Atlas 10th Edition. (2021)."},{"key":"2688_CR6","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.3390\/ijms21176275","volume":"21","author":"U Galicia-Garcia","year":"2020","unstructured":"Galicia-Garcia, U. et al. Pathophysiology of type 2 diabetes mellitus. Int. J. Mol. Sci. 21, 6275 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"2688_CR7","doi-asserted-by":"publisher","first-page":"e000304","DOI":"10.1136\/bmjdrc-2016-000304","volume":"5","author":"AC Hernandez-Romieu","year":"2017","unstructured":"Hernandez-Romieu, A. C., Garg, S., Rosenberg, E. S., Thompson-Paul, A. M. & Skarbinski, J. Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009\u20132010. BMJ Open Diabetes Res. Care 5, e000304 (2017).","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"2688_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.676979","author":"JC Lopez-Alvarenga","year":"2021","unstructured":"Lopez-Alvarenga, J. C. et al. Association of HIV-1 infection and antiretroviral therapy with type 2 diabetes in the hispanic population of the Rio Grande Valley, Texas, USA. Front. Med. https:\/\/doi.org\/10.3389\/fmed.2021.676979 (2021).","journal-title":"Front. Med."},{"key":"2688_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-018-1076-3","author":"EC Noubissi","year":"2018","unstructured":"Noubissi, E. C., Katte, J. C. & Sobngwi, E. Diabetes and HIV. Curr. Diab. Rep. https:\/\/doi.org\/10.1007\/s11892-018-1076-3 (2018).","journal-title":"Curr. Diab. Rep."},{"issue":"2","key":"2688_CR10","doi-asserted-by":"publisher","first-page":"100205","DOI":"10.1016\/j.xcrm.2021.100205","volume":"2","author":"CN Wanjalla","year":"2021","unstructured":"Wanjalla, C. N. et al. Single-cell analysis shows that adipose tissue of persons with both HIV and diabetes is enriched for clonal, cytotoxic, and CMV-specific CD4+ T cells. Cell Rep. Med. 2(2), 100205. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100205 (2021).","journal-title":"Cell Rep. Med."},{"key":"2688_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-180","author":"P Freitas","year":"2012","unstructured":"Freitas, P. et al. Lipodystrophy defined by fat mass ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistance. BMC Infect. Dis. https:\/\/doi.org\/10.1186\/1471-2334-12-180 (2012).","journal-title":"BMC Infect. Dis."},{"key":"2688_CR12","doi-asserted-by":"publisher","first-page":"E2234","DOI":"10.1093\/cid\/ciaa1403","volume":"73","author":"PF Rebeiro","year":"2021","unstructured":"Rebeiro, P. F. et al. Risk of incident diabetes mellitus, weight gain, and their relationships with integrase inhibitor-based initial antiretroviral therapy among persons with human immunodeficiency virus in the United States and Canada. Clin. Infect. Dis. 73, E2234\u2013E2242 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"2688_CR13","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1097\/QAD.0000000000003348","volume":"36","author":"G Spieler","year":"2022","unstructured":"Spieler, G. et al. Trends in diabetes incidence and associated risk factors among people with HIV in the current treatment era. AIDS 36, 1811\u20131818 (2022).","journal-title":"AIDS"},{"key":"2688_CR14","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.1093\/jac\/dkaa330","volume":"75","author":"A Ursenbach","year":"2020","unstructured":"Ursenbach, A. et al. Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: A French multicentre retrospective study. J. Antimicrob. Chemother. 75, 3344\u20133348 (2020).","journal-title":"J. Antimicrob. Chemother."},{"key":"2688_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-021-01382-8","author":"S Sarkar","year":"2021","unstructured":"Sarkar, S. & Brown, T. T. Diabetes in people with HIV. Curr. Diabetes Rep. https:\/\/doi.org\/10.1007\/s11892-021-01382-8 (2021).","journal-title":"Curr. Diabetes Rep."},{"key":"2688_CR16","doi-asserted-by":"publisher","first-page":"E471","DOI":"10.1093\/cid\/ciaa177","volume":"71","author":"JE Lake","year":"2020","unstructured":"Lake, J. E. et al. Risk factors for weight gain following switch to integrase inhibitor-based antiretroviral therapy. Clin. Infect. Dis. 71, E471\u2013E477 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"2688_CR17","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/cid\/ciz999","volume":"71","author":"PE Sax","year":"2020","unstructured":"Sax, P. E. et al. Weight gain following initiation of antiretroviral therapy: Risk factors in randomized comparative clinical trials. Clin. Infect. Dis. 71, 1379\u20131389 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"2688_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25484","author":"K Bourgi","year":"2020","unstructured":"Bourgi, K. et al. Weight gain among treatment\u2010na\u00efve persons with HIV starting integrase inhibitors compared to non\u2010nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada. J. Int. AIDS Soc. https:\/\/doi.org\/10.1002\/jia2.25484 (2020).","journal-title":"J. Int. AIDS Soc."},{"key":"2688_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/QAI.0000000000001071","volume":"73","author":"M Herrin","year":"2016","unstructured":"Herrin, M. et al. Weight gain and incident diabetes among HIV-infected veterans initiating antiretroviral therapy compared with uninfected individuals. JAIDS J. Acquir. Immune Defic. Syndr. 73, 228\u2013236 (2016).","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"2688_CR20","doi-asserted-by":"publisher","first-page":"E549","DOI":"10.1093\/cid\/ciaa259","volume":"71","author":"J Gorwood","year":"2020","unstructured":"Gorwood, J. et al. The integrase inhibitors dolutegravir and raltegravir exert proadipogenic and profibrotic effects and induce insulin resistance in human\/simian adipose tissue and human adipocytes. Clin. Infect. Dis. 71, E549\u2013E560 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"2688_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/QAD.0000000000002718","volume":"35","author":"R Hsu","year":"2021","unstructured":"Hsu, R. et al. Incident type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs. AIDS 35, 81\u201390 (2021).","journal-title":"AIDS"},{"key":"2688_CR22","unstructured":"European Centre for Disease Prevention and Control\/WHO Regional Office for Europe. HIV\/AIDS Surveillance in Europe 2023 \u2013 2022 Data. (2023)."},{"key":"2688_CR23","unstructured":"Minist\u00e9rio da Sa\u00fade. Dire\u00e7\u00e3o-Geral da Sa\u00fade\/Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge. Infe\u00e7\u00e3o Por VIH Em Portugal \u2013 2023. (2023)."},{"key":"2688_CR24","unstructured":"Sociedade Portuguesa de Diabetologia. Diabetes: Factos e N\u00fameros - O Ano de 2019, 2020 e 2021 - Relat\u00f3rio Anual Do Observat\u00f3rio Nacional Da Diabetes. (2023)."},{"key":"2688_CR25","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1093\/cid\/ciac355","volume":"75","author":"JA O\u2019Halloran","year":"2022","unstructured":"O\u2019Halloran, J. A. et al. Integrase Strand Transfer Inhibitors Are Associated With Incident Diabetes Mellitus in People With Human Immunodeficiency Virus. Clin. Infect. Dis 75, 2060\u20132065 (2022).","journal-title":"Clin. Infect. Dis"},{"key":"2688_CR26","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/jcph.473","volume":"55","author":"M Myerson","year":"2015","unstructured":"Myerson, M., Malvestutto, C. & Aberg, J. A. Management of lipid disorders in patients living with HIV. J. Clin. Pharmacol. 55, 957\u2013974 (2015).","journal-title":"J. Clin. Pharmacol."},{"key":"2688_CR27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.amjcard.2005.03.085","volume":"96","author":"T McLaughlin","year":"2005","unstructured":"McLaughlin, T. et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?. Am. J. Cardiol. 96, 399\u2013404 (2005).","journal-title":"Am. J. Cardiol."},{"key":"2688_CR28","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.hlc.2019.03.019","volume":"29","author":"R Sultani","year":"2020","unstructured":"Sultani, R. et al. Elevated triglycerides to high-density lipoprotein cholesterol (TG\/HDL-C) ratio predicts long-term mortality in high-risk patients. Heart Lung Circ. 29, 414\u2013421 (2020).","journal-title":"Heart Lung Circ."},{"key":"2688_CR29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12944-019-1098-0","volume":"18","author":"I Wakabayashi","year":"2019","unstructured":"Wakabayashi, I. & Daimon, T. Comparison of discrimination for cardio-metabolic risk by different cut-off values of the ratio of triglycerides to HDL cholesterol. Lipids Health Dis. 18, 156 (2019).","journal-title":"Lipids Health Dis."},{"key":"2688_CR30","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/ije\/dyi167","volume":"34","author":"SC Maty","year":"2005","unstructured":"Maty, S. C., Everson-Rose, S. A., Haan, M. N., Raghunathan, T. E. & Kaplan, G. A. Education, income, occupation, and the 34-year incidence (1965\u201399) of Type 2 diabetes in the Alameda County Study. Int. J. Epidemiol. 34, 1274\u20131281 (2005).","journal-title":"Int. J. Epidemiol."},{"key":"2688_CR31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/apt.12234","volume":"37","author":"ZM Younossi","year":"2013","unstructured":"Younossi, Z. M., Stepanova, M., Nader, F., Younossi, Z. & Elsheikh, E. Associations of chronic hepatitis C with metabolic and cardiac outcomes. Aliment. Pharmacol. Ther. 37, 647\u2013652 (2013).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"2688_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cphy.c110062","volume-title":"Comprehensive Physiology","author":"CK Roberts","year":"2013","unstructured":"Roberts, C. K., Hevener, A. L. & James Barnard, R. Metabolic syndrome and insulin resistance: Underlying causes and modification by exercise training. In Comprehensive Physiology (ed. Prakash, Y. S.) 1\u201358. https:\/\/doi.org\/10.1002\/cphy.c110062 (Wiley, 2011)."},{"issue":"9","key":"2688_CR33","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.2337\/dc15-0710","volume":"38","author":"C Knott","year":"2015","unstructured":"Knott, C., Bell, S. & Britton, A. Alcohol consumption and the risk of type 2 diabetes: A systematic review and dose-response meta-analysis of more than 1.9 million individuals from 38 observational studies. Diabetes Care 38(9), 1804\u20131812. https:\/\/doi.org\/10.2337\/dc15-0710 (2015).","journal-title":"Diabetes Care"},{"key":"2688_CR34","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1097\/QAD.0000000000001248","volume":"30","author":"PM Grant","year":"2016","unstructured":"Grant, P. M. et al. Long-term body composition changes in antiretroviral-treated HIV-infected individuals. AIDS 30, 2805\u20132813 (2016).","journal-title":"AIDS"},{"key":"2688_CR35","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/cid\/ciz407","volume":"70","author":"K Bourgi","year":"2020","unstructured":"Bourgi, K. et al. Greater weight gain in treatment-naive persons starting dolutegravir-based antiretroviral therapy. Clin. Infect. Dis. 70, 1267\u20131274 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"2688_CR36","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1097\/QAD.0000000000002930","volume":"35","author":"K McCann","year":"2021","unstructured":"McCann, K. et al. Implications of weight gain with newer anti-retrovirals: 10-year predictions of cardiovascular disease and diabetes. AIDS 35, 1657\u20131665 (2021).","journal-title":"AIDS"},{"key":"2688_CR37","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/s00125-019-4934-x","volume":"62","author":"AK Palmer","year":"2019","unstructured":"Palmer, A. K., Gustafson, B., Kirkland, J. L. & Smith, U. Cellular senescence: At the nexus between ageing and diabetes. Diabetologia 62, 1835\u20131841 (2019).","journal-title":"Diabetologia"},{"key":"2688_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00681","author":"JS Neves","year":"2018","unstructured":"Neves, J. S. et al. Metabolically healthy or metabolically unhealthy obese HIV-infected patients: Mostly a matter of age?. Front. Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2018.00681 (2018).","journal-title":"Front. Endocrinol."},{"key":"2688_CR39","doi-asserted-by":"publisher","first-page":"109980","DOI":"10.1016\/j.diabres.2022.109980","volume":"190","author":"JS Neves","year":"2022","unstructured":"Neves, J. S. et al. Management of dyslipidemia and atherosclerotic cardiovascular risk in prediabetes. Diabetes Res. Clin. Pract. 190, 109980. https:\/\/doi.org\/10.1016\/j.diabres.2022.109980 (2022).","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"7","key":"2688_CR40","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s00125-010-1684-1","volume":"53","author":"RA DeFronzo","year":"2010","unstructured":"DeFronzo, R. A. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: The missing links. The Claude Bernard Lecture 2009. Diabetologia 53(7), 1270\u20131287. https:\/\/doi.org\/10.1007\/s00125-010-1684-1 (2010).","journal-title":"Diabetologia"},{"key":"2688_CR41","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.2337\/dc10-0633","volume":"33","author":"TT Brown","year":"2010","unstructured":"Brown, T. T., Tassiopoulos, K., Bosch, R. J., Shikuma, C. & McComsey, G. A. Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy. Diabetes Care 33, 2244\u20132249 (2010).","journal-title":"Diabetes Care"},{"key":"2688_CR42","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1086\/374786","volume":"187","author":"PW Hunt","year":"2003","unstructured":"Hunt, P. W. et al. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J. Infect. Dis. 187, 1534\u20131543 (2003).","journal-title":"J. Infect. Dis."},{"key":"2688_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw174","author":"S Dirajlal-Fargo","year":"2016","unstructured":"Dirajlal-Fargo, S. et al. Changes in insulin resistance after initiation of raltegravir or protease inhibitors with tenofovir-emtricitabine: AIDS clinical trials group A5260s. Open Forum Infect. Dis. https:\/\/doi.org\/10.1093\/ofid\/ofw174 (2016).","journal-title":"Open Forum Infect. Dis."},{"key":"2688_CR44","doi-asserted-by":"publisher","first-page":"F11","DOI":"10.1097\/00002030-200105040-00001","volume":"15","author":"MA Noor","year":"2001","unstructured":"Noor, M. A. et al. Metabolic effects of indinavir in healthy HIV-seronegative men. AIDS 15, F11 (2001).","journal-title":"AIDS"},{"issue":"11","key":"2688_CR45","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.3390\/cells11111841","volume":"11","author":"KN Ayissi","year":"2022","unstructured":"Ayissi, K. N. et al. Inhibition of adipose tissue beiging by HIV integrase inhibitors, dolutegravir and bictegravir, is associated with adipocyte hypertrophy, hypoxia, elevated fibrosis, and insulin resistance in simian adipose tissue and human adipocytes. Cells 11(11), 1841. https:\/\/doi.org\/10.3390\/cells11111841 (2022).","journal-title":"Cells"},{"key":"2688_CR46","doi-asserted-by":"publisher","first-page":"120948","DOI":"10.1016\/j.lfs.2022.120948","volume":"308","author":"P Domingo","year":"2022","unstructured":"Domingo, P. et al. Differential effects of dolutegravir, bictegravir and raltegravir in adipokines and inflammation markers on human adipocytes. Life Sci. 308, 120948 (2022).","journal-title":"Life Sci."},{"key":"2688_CR47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s40262-016-0424-1","volume":"56","author":"AT Podany","year":"2017","unstructured":"Podany, A. T., Scarsi, K. K. & Fletcher, C. V. comparative clinical pharmacokinetics and pharmacodynamics of HIV-1 integrase strand transfer inhibitors. Clin. Pharmacokinet. 56, 25\u201340 (2017).","journal-title":"Clin. Pharmacokinet."},{"key":"2688_CR48","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s40262-013-0093-2","volume":"52","author":"ML Cottrell","year":"2013","unstructured":"Cottrell, M. L., Hadzic, T. & Kashuba, A. D. M. Clinical pharmacokinetic, pharmacodynamic and drug-interaction profile of the integrase inhibitor dolutegravir. Clin. Pharmacokinet. 52, 981\u2013994 (2013).","journal-title":"Clin. Pharmacokinet."},{"key":"2688_CR49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/QAI.0000000000001306","volume":"75","author":"JE Gallant","year":"2017","unstructured":"Gallant, J. E. et al. Antiviral activity, safety, and pharmacokinetics of bictegravir as 10-day monotherapy in HIV-1\u2013infected adults. JAIDS J. Acquir. Immune Defic. Syndr. 75, 61\u201366 (2017).","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"2688_CR50","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.126675","author":"M Korencak","year":"2019","unstructured":"Korencak, M. et al. Effect of HIV infection and antiretroviral therapy on immune cellular functions. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.126675 (2019).","journal-title":"JCI Insight"},{"key":"2688_CR51","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.diabet.2019.02.008","volume":"45","author":"JP Bastard","year":"2019","unstructured":"Bastard, J. P. et al. Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients. Diabetes Metab. 45, 573\u2013581 (2019).","journal-title":"Diabetes Metab."},{"key":"2688_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26123","author":"PF Rebeiro","year":"2023","unstructured":"Rebeiro, P. F. et al. Incidence of cardiometabolic outcomes among people living with HIV\u20101 initiated on integrase strand transfer inhibitor versus non\u2010integrase strand transfer inhibitor antiretroviral therapies: A retrospective analysis of insurance claims in the United States. J. Int. AIDS Soc. https:\/\/doi.org\/10.1002\/jia2.26123 (2023).","journal-title":"J. Int. AIDS Soc."},{"key":"2688_CR53","unstructured":"Minist\u00e9rio da Sa\u00fade. Dire\u00e7\u00e3o-Geral da Sa\u00fade\/Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge. Infe\u00e7\u00e3o Por VIH Em Portugal - 2022. (2022)."},{"key":"2688_CR54","doi-asserted-by":"crossref","unstructured":"Classification and diagnosis of diabetes: Standards of medical care in diabetes-2022. Diabetes Care 45, S17\u2013S38 (2022).","DOI":"10.2337\/dc22-S002"},{"key":"2688_CR55","doi-asserted-by":"publisher","first-page":"BMI.S38440","DOI":"10.4137\/BMI.S38440","volume":"11","author":"SI Sherwani","year":"2016","unstructured":"Sherwani, S. I., Khan, H. A., Ekhzaimy, A., Masood, A. & Sakharkar, M. K. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark. Insights 11, BMI.S38440. https:\/\/doi.org\/10.4137\/BMI.S38440 (2016).","journal-title":"Biomark. Insights"},{"key":"2688_CR56","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/QAI.0000000000000983","volume":"72","author":"IH Song","year":"2016","unstructured":"Song, I. H. et al. The effect of dolutegravir on the pharmacokinetics of metformin in healthy subjects. JAIDS J. Acquir. Immune Defic. Syndr. 72, 400\u2013407 (2016).","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"2688_CR57","unstructured":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm. Rep. 41, 1\u201319 (1992)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02688-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02688-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02688-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T00:16:01Z","timestamp":1751760961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02688-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2688"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-02688-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"21 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Medical Ethics Committee (Comiss\u00e3o de \u00c9tica para a Sa\u00fade) of Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o (Project number 179\/2023). Consent to participate does not apply for this type of study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"20439"}}